NRG Oncology/Alliance Study Shows Adding Immunotherapy to Chemoradiotherapy Fails to Extend Survival in Small Cell Lung Cancer
In the evolving landscape of oncology, a pivotal international phase III clinical trial—NRG-LU005—has recently reshaped the understanding of treatment paradigms ...
